Skip to main content
SearchLoginLogin or Signup

Reviews of "Monkeypox Outbreak in the Netherlands in 2022: Public Health Response, Epidemiological and Clinical Characteristics of the First 1000 Cases and Protection of the First-Generation Smallpox Vaccine"

Reviewer: S. Nasreen (University of Toronto) | 📗📗📗📗◻️

Published onDec 29, 2022
Reviews of "Monkeypox Outbreak in the Netherlands in 2022: Public Health Response, Epidemiological and Clinical Characteristics of the First 1000 Cases and Protection of the First-Generation Smallpox Vaccine"
key-enterThis Pub is a Review of
Monkeypox outbreak in the Netherlands in 2022: public health response, epidemiological and clinical characteristics of the first 1000 cases and protection of the first-generation smallpox vaccine
Description

AbstractIn early May 2022 a global outbreak of monkeypox (MPX) started among persons without a travel history to regions known to be enzootic for monkeypox-virus. On August 8 2022, the Netherlands reported its 1000thmonkeypox case representing a cumulative incidence of 55 per million population, one of the highest cumulative incidences worldwide. Here we describe the epidemiological characteristics and clinical presentation of the first 1000 monkeypox cases in the Netherlands, within the context of the public health response. Additionally, we explored risk factors for and estimated the protective effect of first-generation smallpox vaccine against more severe MPX.The first 1000 MPX cases, reported between May 20 and August 8 2022, were predominantly MSM aged 31-45 years. The vast majority of infections were acquired through sexual contact with casual partners in private or recreational settings including LGBTQIA+ venues in the Netherlands. This indicates that, although some larger upsurges occurred from point-source and/or travel related events, the outbreak is mainly characterised by sustained transmission within the Netherlands. More severe MPX was associated with having one or more comorbidities as well as having participated in more (3+) different sexual activities 21 days before symptom onset. We found a vaccine effectiveness of the prior first-generation smallpox vaccine against more severe MPX of 58% (95% CI 17-78%), suggesting moderate protection against more severe MPX symptoms on top of any possible protection by this vaccine against MPXV infection and disease.

To read the original manuscript, click the link above.

Reviewer 1 (Sharifa N…) | 📗📗📗📗◻️

RR:C19 Strength of Evidence Scale Key

📕 ◻️◻️◻️◻️ = Misleading

📙📙 ◻️◻️◻️ = Not Informative

📒📒📒 ◻️◻️ = Potentially Informative

📗📗📗📗◻️ = Reliable

📘📘📘📘📘 = Strong

To read the reviews, click the links below. 

Comments
1
Bryce Wo:

The RDF shredder separates waste into two parts: combustible and non-combustible.

The first step is pre-treatment, which breaks down the waste into smaller pieces and removes non-combustible material. This can include bag breaking, primary magnetic separation, or other methods.